Skip to content

Clinical comprehensive evaluation of matrine film agent in the treatment of postpartum vaginal microecological disorders

Clinical comprehensive evaluation of matrine film agent in the treatment of postpartum vaginal microecological disorders

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400080732
Enrollment
Unknown
Registered
2024-02-05
Start date
2023-10-26
Completion date
Unknown
Last updated
2024-02-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postpartum 6-8 weeks vaginal microecology disorder

Interventions

control group:conventional therapy
treatment group:conventional therapy + matrine film agent

Sponsors

Guizhou Provincial People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 40 Years

Inclusion criteria

Inclusion criteria: ? Women between 20 and 40 years old; ? Postpartum 6-8 weeks, lochia clean, diagnosed by clinicians and laboratory indicators as vaginal microecological disorders; ? Women who voluntarily participate and are easily followed up on time; ? Sign informed consent.

Exclusion criteria

Exclusion criteria: ? Women with unstable vital signs and severe speech or intellectual disabilities, mental patients or other women who cannot cooperate with treatment; ? Women allergic to matrine film agent.

Design outcomes

Primary

MeasureTime frame
Efficiency of microecological improvement;

Secondary

MeasureTime frame
Vaginal health score;Vaginal inflammation score;Quality of life for women;Incremental cost-effectiveness ratio;

Countries

China

Contacts

Public ContactJiaxing Zhang

Guizhou Provincial People's Hospital

zjx19870619@126.com+86 139 8481 7008

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026